通知通告

新闻类别:通知通告
2017-05-10

【报告通知】Nanotools for Cytokien Monitoring in Neuroscience

报告题目:Nanotools for Cytokien Monitoring in Neuroscience
报告时间:2017年5月11日(本周四)上午10:00
报告地点:武汉光电国家实验室G301
报 告 人:刘国珍,澳大利亚纳米尺度生物光子学中心、麦考瑞大学 博士
邀 请 人:张智红教授

Abstract:
Cytokines secreted from cells play critical roles in tissue repair, cancer development and progression. Elevated cytokine secretion is closely related to many  brain diseases.  Unfortunately, probing what cells “see”, and what they secrete as they respond in real time to the surrounding signals is still a major challenge. The ultra-low concentration of cytokine (in the pM range), and extremely dynamic, transient cytokine secretion process make cytokine quantification even difficult. By integrating with nanotechnology, biosensors as the analytical devices for the detection of an analyte, that combines a biological component with a physicochemical detector, have demonstrated huge potential for cytokine sensing. In this talk, Liu will summarize her recent research highlights on development of biosensors for detection of cytokines.  Liu will also detail the development of in vivo devices for spatially cytokine monitoring in neuroscience.

Simple Biography:
Dr. Guozhen Liu is an ARC Future Fellow, who holds a Master degree (2000) in Analytical Chemistry from the China University of Geosciences, and a PhD (2006) in Chemistry from Prof Justin Gooding's group at the University of New South Wales (UNSW). Dr. Liu conducted her postdoctoral research at CSIRO (2006-2008) and UNSW (2008-2010), respectively before she accepted a full time position of Associate Professor at the Central China Normal University. Meanwhile, Dr. Liu achieved her industrial experience as the R&D Manager, China (2011-2015) on developing medical devices at AgaMatrix Inc., a US based company for making glucose test strips and glucose meters. Before Liu was awarded the ARC Future Fellowship, Liu worked as the Research Fellow of ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) (2015-2016). Liu has attracted more than $1.7M research funding from both Australia and China.